mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.029 |
0.4 |
mRNA |
BRD-K99584050 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.4 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.034 |
0.4 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.4 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.4 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.032 |
0.4 |